GEN Quote, Trading Chart, Genesis Healthcare Inc.

$0.8621 Last:

-9.25% Change Percent:

$0.95 Open:

$0.8621 Previous Close:

$0.98 High:

$0.85 Low:

1,476,554 Volume:

05/29/2020 04:57:30 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2020-05-29	0.95	0.8621	0.98	0.85	1,476,554
2020-05-28	1.05	0.95	1.1	0.9448	1,572,116
2020-05-27	1.28	1.01	1.29	0.97	3,951,379
2020-05-26	1.13	1.16	1.37	1.1	4,656,498
2020-05-25	0.81	1.04	1.25	0.8075	6,480,562
2020-05-22	0.81	1.04	1.25	0.8075	6,457,568
2020-05-21	0.659	0.77	0.8199	0.652	1,873,344
2020-05-20	0.649	0.625	0.6676	0.608	1,815,183
2020-05-19	0.63	0.6221	0.66	0.6053	720,926
2020-05-18	0.6677	0.628	0.6677	0.6	871,450
2020-05-15	0.6364	0.5947	0.6364	0.58	583,111
2020-05-14	0.6796	0.6119	0.6796	0.603	636,264
2020-05-13	0.6924	0.6686	0.6924	0.64	682,425
2020-05-12	0.74	0.6924	0.75	0.6924	1,299,617
2020-05-11	0.715	0.702	0.74	0.6905	438,175
2020-05-08	0.69	0.7104	0.76	0.68	765,828
2020-05-07	0.7269	0.7195	0.75	0.69	365,625
2020-05-06	0.8098	0.7135	0.81	0.705	435,785
2020-05-05	0.7718	0.7705	0.8198	0.7693	246,635
2020-05-04	0.85	0.8005	0.88	0.775	424,418

Stock Information

Genesis Healthcare Inc. Company Name:

GEN Stock Symbol:

NYSE Market:

Genesis Healthcare Inc. Website:

Get GEN Alerts

News, Short Squeeze, Breakout and More Instantly...

GEN - ARNC, ALXN among premarket gainers

ARCA biopharma (NASDAQ: ABIO ) +59% on launching AB201 program in COVID-19. More news on: ARCA biopharma, Inc., PhaseBio Pharmaceuticals, Inc., Technical Communications Corporation, Stocks on the move, , Read more ...
GEN - Genesis Healthcare, Inc. (GEN) CEO George Hager on Q1 2020 Results - Earnings Call Transcript

Genesis Healthcare, Inc. (GEN) Q1 2020 Earnings Conference Call May 27, 2020 8:30 AM ET Company Participants Lori Mayer - VP Investor Relations George Hager - Chief Executive Officer Richard Feifer - Chief Medical Officer Tom DiVittorio - Chief Financial Officer Conference C...
GEN - AAL, CCL among premarket gainers

Mersana Therapeutics (NASDAQ: MRSN ) +42% as XMT-1536 shows positive action in ovarian cancer. More news on: Mersana Therapeutics, Inc., Phunware, Inc., Luckin Coffee Inc., Stocks on the move, , Read more ...